about
Integrative Therapies and Cardiovascular Disease in the Breast Cancer Population: A Review, Part 12015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theIschemic Heart Disease: Special Considerations in Cardio-Oncology.The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracil.Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.Mechanisms of Cardiotoxicity of Cancer Chemotherapeutic Agents: Cardiomyopathy and Beyond.Chemotherapy and cardiotoxicity5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.Cardio-oncology Part I: chemotherapy and cardiovascular toxicity.Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.Fluoropyrimidine-Induced Cardiotoxicity: Manifestations, Mechanisms, and Management.Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity.5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress.The anti-cancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate.5-Ethynyluracil (GW776): effects on the formation of the toxic catabolites of 5-fluorouracil, fluoroacetate and fluorohydroxypropionic acid in the isolated perfused rat liver model.5-Fluorouracil-induced cardiotoxicity during chemotherapy for adenocarcinoma of the small bowel.Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.Coronary artery spasm induced by 5-fluorouracil.Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.5-fluorouracil and cardiotoxicity: a review.
P2860
Q26771931-5153748A-12BC-4944-9B87-F79CFBF6925BQ28087002-5B464E35-28D8-47D4-ADE1-04A5337F84BAQ33441165-CBC2ED94-C949-44D8-B37C-847D4E2D4F5CQ34761260-6A65206D-3DEE-4FB8-81AA-9817EF213BF5Q36292188-9255C9CF-9B28-4CC7-85D7-5F5A93791055Q37038711-530F57FC-6D30-47A9-8496-5E89BD3AFA2CQ37045339-B5FFE8A5-3658-40B8-A0D8-2C53237CE237Q38067509-680FF47A-1EDB-43D6-A956-31BDCFA03A9BQ38097736-42866677-A6F6-450A-9788-30CE833C2A5EQ38406251-71719CA8-145B-4CBA-B2D2-64FFABC4B46FQ38735433-3CB08709-4B1E-410B-B054-9EFFC556FF22Q38817372-D1F8E765-8692-41D5-B2F1-E48FEB1E25DEQ38834995-72093623-9A90-4B5A-ABA8-F79FE1313441Q39311982-EAB03FA5-4023-4D2A-93A3-16129F93681DQ41877476-7FDAB760-5D20-4328-869E-C1E60CAF7E8BQ41931588-6FF79A58-1BC6-41B1-8F4E-A34272AE7AD9Q42267570-C466A57C-D8E8-4DA9-A716-204D538633ACQ43042597-0BF3CEEA-BF8B-4013-9D57-07EC3C6DA69DQ45073135-F557BF59-B275-4179-BF73-B754721BDC64Q45237039-68926055-6F2D-4ED3-87F4-A4AB332F297CQ45258221-1DDA9172-09D8-4B62-8FFE-F343CC84FAC5Q52982588-8193B133-24D2-4E0B-9502-45D36008AC8DQ55515022-7ABCD852-E1E7-4606-A8D2-5C5E588DC766
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Fluorouracil cardiotoxicity.
@en
type
label
Fluorouracil cardiotoxicity.
@en
prefLabel
Fluorouracil cardiotoxicity.
@en
P2860
P1476
Fluorouracil cardiotoxicity.
@en
P2093
P2860
P304
P356
10.1177/106002809402800314
P407
P577
1994-03-01T00:00:00Z